Compounded GLP-1 Medications in 2026: What Patients Need to Know Before Ordering Online

GLP-1 medications have changed the conversation around weight management and metabolic health, but many patients are still unsure about one important question: are compounded GLP-1 medications still a good option in 2026? The safest answer is that patients should be cautious, especially when these products are marketed online with limited medical oversight. [Source]

The FDA says the shortages of tirzepatide and semaglutide injection products have been resolved, which means the regulatory basis for widespread routine compounding is much narrower than it was during the shortage period. Tirzepatide shortage was declared resolved in December 2024, and semaglutide injection shortage was declared resolved in February 2025. [Source]

Looking for medically guided weight and metabolic care? See Zara Medical’s primary care and chronic condition services, review visit pricing, or send a message to ask whether a medication visit is right for you.

What changed with semaglutide and tirzepatide?

According to the FDA, once semaglutide and tirzepatide were no longer listed as being in shortage, compounders generally could not keep producing products that are essentially copies of commercially available FDA-approved drugs unless narrow conditions were met. For patients, that means it is important to ask whether the product you are being offered is FDA-approved, appropriately prescribed, and coming from a legitimate pharmacy source. [Source]

Why the FDA is concerned

The FDA says compounded drugs do not undergo the same review for safety, effectiveness, and quality as FDA-approved medications. On its GLP-1 safety page, the agency highlights several concerns: dosing errors, fraudulent labels, improper shipping temperatures, counterfeit products, and illegally marketed online versions that may contain the wrong amount of active ingredient or other harmful substances. [Source]

Dosing errors can send patients to the hospital

One of the biggest risks with compounded injectable GLP-1 medications is dose confusion. Some patients are required to measure doses manually instead of using the standardized pen devices used with approved products. The FDA says it has received multiple reports of adverse events, some requiring hospitalization, related to dosing errors with compounded semaglutide and tirzepatide. Symptoms reported included nausea, vomiting, diarrhea, abdominal pain, and constipation. [Source]

Online ordering adds another layer of risk

The FDA also warns about fake or illegally marketed GLP-1 products sold online. Some may be falsely labeled “for research purposes” or “not for human consumption,” yet still sold to consumers with dosing instructions. The agency also notes that some compounded injectable GLP-1 products have arrived warm or without sufficient refrigeration, which may affect product quality. [Source]

How common are reported problems?

As of July 31, 2025, the FDA had received 605 adverse event reports associated with compounded semaglutide and 545 reports associated with compounded tirzepatide. These reports do not prove every event was caused by the compounded product alone, but they do show that these are not trivial quality or safety concerns. [Source]

What patients should do instead

If you are thinking about a GLP-1 medication for weight loss, insulin resistance, obesity, or related metabolic issues, the safest path is to start with a medical evaluation. Work with a licensed clinician, confirm that you are an appropriate candidate, review side effects and contraindications, and fill prescriptions through a state-licensed pharmacy. [Source]

Zara Medical can help patients review weight-related concerns as part of broader primary care and chronic disease management, especially when the goal is not just weight change but better blood pressure, glucose control, energy, and long-term health.

Bottom line

In 2026, the safest patient guidance is simple: be cautious with compounded GLP-1 medications, especially those marketed online. FDA-approved options come with stronger safeguards for consistency and quality. If you are exploring medication-assisted weight care, begin with a legitimate clinical visit instead of an internet shortcut.